Free shipping on all orders over $ 500

Tadalafil

Cat. No. M3473

All AbMole products are for research use only, cannot be used for human consumption.

Tadalafil Structure
Synonym:

IC351

Size Price Availability Quantity
Free Sample (0.5-1 mg)  USD 0 In stock
10mg USD 35  USD35 In stock
50mg USD 80  USD80 In stock
100mg USD 125  USD125 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Tadalafil (Cialis) is a PDE inhibitor. Tadalafil (Cialis), which has demonstrated a high level of selectivity for PDE5 over the other phosphodiesterases, has shown efficacy in improving erectile function and sexual satisfaction in phase III trials. PDE11A3, PDE11A2, and PDE11A1, which contain progressively shorter N-termini, were more sensitive than PDE11A4 to inhibition by Tadalafil (Cialis).

Protocol (for reference only)
Cell Experiment
Cell lines
Preparation method
Concentrations
Incubation time
Animal Experiment
Animal models Sham-operated rats
Formulation Saline
Dosages 2 mg/kg
Administration Orally
Chemical Information
Molecular Weight 389.4
Formula C22H19N3O4
CAS Number 171596-29-5
Solubility (25°C) DMSO 48 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] A Sebastianelli, et al. Tadalafil Alone or in Combination with Tamsulosin for the Management for LUTS/BPH and ED

[2] Olivier Sitbon, et al. Initial combination therapy of macitentan and tadalafil in pulmonary arterial hypertension

[3] Fabiola Zakia Mnica, et al. Tadalafil for the treatment of benign prostatic hyperplasia

[4] Yilin Wang, et al. Tadalafil 5 mg Once Daily Improves Lower Urinary Tract Symptoms and Erectile Dysfunction: A Systematic Review and Meta-analysis

[5] Binbin Gong, et al. Direct comparison of tadalafil with sildenafil for the treatment of erectile dysfunction: a systematic review and meta-analysis

Related PDE Products
MR-L2

MR-L2 is a reversible and noncompetitive allosteric activator of long-isoform phosphodiesterase-4 (PDE4), activates representative PDE4 long-isoform variants (PDE4A4, PDE4B1, PDE4C3, PDE4D5). MR-L2 suppresses PGE2-induced MDCK cell cyst formation with an EC50 of 1.2 μM.

MMPX

MMPX is a potent PDE1 inhibitor.

T-0156 

T-0156 is a potent and selective phosphodiesterase type 5 (PDE5) inhibitor.

TPN171 

TPN171 is a potent, selective and oral bioavailable inhibitor of phosphodiesterase type 5 (PDE5) with an IC50 of 0.62 nM, being developed for the treatment of pulmonary arterial hypertension (PAH).

Mesopram

Mesopram (Daxalipram) is an orally active phosphodiesterase (PDE) 4 inhibitor.

  Catalog
Abmole Inhibitor Catalog




Keywords: Tadalafil, IC351 supplier, PDE, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.